Novo Nordisk A/S
NVO
$44.96
$0.571.28%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 16.17% | 11.16% | 18.66% | 21.48% | 22.67% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.17% | 11.16% | 18.66% | 21.48% | 22.67% |
| Cost of Revenue | 27.30% | 30.58% | 29.95% | 25.09% | 24.10% |
| Gross Profit | 14.16% | 7.73% | 16.64% | 20.83% | 22.41% |
| SG&A Expenses | 1.02% | 5.31% | 9.97% | 14.38% | 9.26% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 162.09% | -115.17% | 751.03% | 245.50% | -144.33% |
| Total Operating Expenses | 17.82% | 20.72% | 15.10% | 15.10% | 12.96% |
| Operating Income | 14.53% | 1.51% | 22.73% | 28.90% | 34.21% |
| Income Before Tax | 26.21% | 6.72% | 12.03% | 25.18% | 16.90% |
| Income Tax Expenses | 30.65% | 11.53% | 16.21% | 29.54% | 21.18% |
| Earnings from Continuing Operations | 25.03% | 5.48% | 10.95% | 24.06% | 15.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 25.03% | 5.48% | 10.95% | 24.06% | 15.82% |
| EBIT | 14.53% | 1.51% | 22.73% | 28.90% | 34.21% |
| EBITDA | 16.82% | 5.59% | 24.73% | 29.01% | 31.79% |
| EPS Basic | 25.18% | 5.74% | 11.32% | 24.60% | 16.43% |
| Normalized Basic EPS | 22.08% | 4.78% | 21.92% | 26.32% | 29.54% |
| EPS Diluted | 25.23% | 5.85% | 11.45% | 24.77% | 16.56% |
| Normalized Diluted EPS | 22.17% | 4.88% | 22.04% | 26.43% | 29.64% |
| Average Basic Shares Outstanding | -0.13% | -0.26% | -0.35% | -0.43% | -0.54% |
| Average Diluted Shares Outstanding | -0.20% | -0.35% | -0.44% | -0.52% | -0.62% |
| Dividend Per Share | 10.74% | 10.74% | 18.93% | 18.93% | 19.95% |
| Payout Ratio | -0.12% | 0.11% | 0.06% | -0.04% | 0.03% |